Antibody directed enzymes revive anti-cancer prodrugs concept

British Journal of Cancer

Volumn 56, Issue 5, 1987, Pages 531-532

  Bagshawe, K D ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PRODRUG;

DRUG TARGETING; EDITORIAL; METHODOLOGY; NONHUMAN; THERAPY;

ANIMAL; ANTIBODIES; ANTINEOPLASTIC AGENTS; DRUG THERAPY; ENZYMES; HUMAN; PRODRUGS; RATS;

EID: 0023619243     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1987.237     Document Type: Article

References (13)

1. BAGSHAWE, K.D. (1983). Tumour markers - Where do we go from here? Third Gordon Hamilton-Fairley Memorial Lecture. Br. J. Cancer, 48, 167-175.
2. BAGSHAWE, K.D. (1985). Cancer drug targeting. Clin. Radiol., 36, 545.
3. CARL, P.L., CHAKRAVARTY, P.K., KATZENELLENBOGEN, J.A. & WEBER, M.J. (1980). Protease-activated 'prodrugs' for cancer chemotherapy. Proc. Natl Acad. Sci. USA, 77, 2224.
4. COBB, L.M., CONNORS, T.A., ELSON, L.A. & 4 others (1969). 2, 4- dinitro-5-ethyleneiminobenzamide (CB1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem. Pharmacol., 18, 1519.
5. CONNORS, T.A. & MELZACK, D.H. (1971). Studies on the mechanisms of action of 5-aziridinyl-2-4-dinitrobenzamide (CB1954): A selective inhibitor of the Walker tumour. Int. J. Cancer, 7, 86.
6. CONNORS, T.A. (1978). Antitumor drugs with latent activity. Biochemia, 60, 979.
7. JAFFERS, G.J., FULLER, T.C., COSIMI, A.B., RUSSELL, P.S., WINN, H.J. & CALVIN, R.B. (1986). Monoclonal antibody therapy. Antiidiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immuno-suppression. Transplantation, 41, 572.
8. LEDERMANN, J.A., BEGENT, R.H.J. & BAGSHAWE, K.D. (1987). Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits (in press).
9. 2 conjugates as potential tumour imaging agent. Proc. NA TO Workshop on Monoclonal Antibodies for Imaging and Therapy. Castel Vecchio, Cascoli, July 1986.
10. NEUBERGER, M.S., WILLIAMS, G.T. & FOX, R.O. (1984). Recombinant antibodies possessing novel effector functions. Nature, 312, 604.
11. ROBERTS, J.J., FRIEDLAS, F. & KNOW, R.J. (1986). CB1954 (2, 4- dinitro-5-aziridinyl benzamide) becomes a DNA interstrand cross-linking agent in Walker tumour cells. Biochem. Biophys. Res. Comm., 140, 1073.
12. ROSS, W.C.J. & WARWICK, G.P. (1955). Reduction of cytotoxic compounds by hydrazine and by the xanthine oxidase system. Nature, 176, 298.
13. 2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. Br. J. Cancer, 53, 377.